Catalyst Wire Dossier Catalyst Wire Dossier

Yukon Choice PC Sirolimus-Eluting Bioabsorbable Polymer Stent

Sirolimus-eluting bioabsorbable polymer stent · Translumina GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Yukon Choice PC Sirolimus-Eluting Bioabsorbable Polymer Stent, covering 2024-05-08 to 2024-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Observatory to Assess the Yukon Choice PC & the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Stents Systems

See pricing